By subjecting CGB lectin-captured glycoprotein fractions of serum PCA isolates of the stage 0 and stage I breast cancer patients and those of controls to SDS-PAGE, we were able to further show that the intensities of proteoglycan 4 and plasma protease C1 inhibitor bands were differently altered. Here, PRG4 is linked to breast carcinoma.